Watch DLB. Know when insiders buy.
One email the day a filing lands. Free.
DLB
Dolby Laboratories, Inc.
62.52
+0.21 +0.34%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
46
WATCH · insiders 26, shorts 66
Insiders, 90 days
−$996K
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E 26.6DIV YIELD 2.26%FCF YIELD —REV TTM $1.4B +0.6%NET INCOME $226.2M −14.4%NET CASH —52W 48.51 – 69.09SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Jun 26 | $305M | −3.3% | 86.8% | $34.3M | $28.6M | −37.9% | 0.30 | $167.5M | $15M | $152.5M | Jul 30 |
| Q2 2026 · Mar 27 | $395.6M | +7.1% | 88.7% | $112.9M | $94.9M | +3.4% | 0.99 | $92.5M | $9.1M | $83.4M | Jul 30 |
| Q1 2026 · Dec 26 | $346.7M | −2.9% | 87.5% | $62.2M | $53.3M | −21.4% | 0.55 | $54.8M | $4.6M | $50.2M | Jul 30 |
| Q4 2025 · Sep 26 | $307M | +0.7% | 87.1% | $29.7M | $49.3M | −15.8% | 0.51 | $122.8M | $16.2M | $106.6M | Nov 18 |
| Q3 2025 · Jun 27 | $315.5M | +9.3% | 86.1% | $47.6M | $46.1M | +19.8% | 0.48 | $67.7M | $6.4M | $61.3M | Jul 30 |
| Q2 2025 · Mar 28 | $369.6M | +1.4% | 90.3% | $107.8M | $91.8M | −6.2% | 0.94 | $174.9M | $6.9M | $168M | Apr 30 |
| Q1 2025 · Dec 27 | $357M | +13.1% | 88.6% | $79.9M | $67.8M | +1.3% | 0.70 | $106.8M | $6.8M | $100M | Jan 29 |
| Q4 2024 · Sep 27 | $304.8M | +4.9% | 88.8% | $46.4M | $58.6M | +537.6% | 0.60 | $116.2M | $7.4M | $108.8M | Nov 18 |
| Q3 2024 · Jun 28 | $288.8M | — | 87.7% | $36.8M | $38.4M | — | 0.40 | $21.3M | $7.6M | $13.7M | Jul 31 |
| Q2 2024 · Mar 29 | $364.5M | — | 89.4% | $109M | $97.8M | — | 1.01 | $181.4M | $8.9M | $172.5M | May 1 |
| Q1 2024 · Dec 29 | $315.6M | — | 89.8% | $66.2M | $67M | — | 0.69 | $8.4M | $6.1M | $2.3M | Jan 30 |
| Q4 2023 · Sep 29 | $290.6M | — | 87.8% | −$3.5M | $9.2M | — | 0.09 | $85M | $8.2M | $76.8M | Nov 18 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Sep 26 | $1.3B | 88.1% | $265M | $255M | 18.9% | 2.62 | $472.2M | $36.3M | $435.9M | $125M | $126.6M |
| FY2024 · to Sep 27 | $1.3B | 89.0% | $258.3M | $261.8M | 20.6% | 2.69 | $327.3M | $30M | $297.2M | $160M | $114.6M |
| FY2023 · to Sep 29 | $1.3B | 88.3% | $215.8M | $200.7M | 15.4% | 2.05 | $367.1M | $30.3M | $336.7M | $149.3M | $103.4M |
| FY2022 · to Sep 30 | $1.3B | 88.7% | $206.6M | $184.1M | 14.7% | 1.81 | $318.6M | $47.9M | $270.6M | $530.5M | $100.1M |
| FY2021 · to Sep 24 | $1.3B | 89.9% | $344.4M | $310.2M | 24.2% | 2.97 | $447.8M | $54.5M | $393.3M | $245.9M | $89.2M |
| FY2020 · to Sep 25 | $1.2B | 87.4% | $218.7M | $231.4M | 19.9% | 2.25 | $343.8M | $66.3M | $277.5M | $173.7M | $88.6M |
Every number comes from Dolby Laboratories, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.